Related Experiment Video

Updated: May 19, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

Prolonged jaundice in neonates

Siba Prosad Paul1, Valerie Hall, Timothy Mackford Taylor

  • 1Great Western Hospital, Swindon.

The Practising Midwife
|August 7, 2012
PubMed

Insights

Jaundice in newborns is common, especially in breastfed infants. This study found breastfeeding is the primary cause of prolonged jaundice, suggesting reduced referrals and investigations for well infants.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Public Health

Background:

  • Jaundice is a frequent condition in newborns, often prompting parental consultation with healthcare providers.
  • Up to 40% of breastfed infants exhibit jaundice at 14 days, leading to referrals for pediatric assessment.
  • Many referrals reveal elevated bilirubin without other liver abnormalities, diagnosing breastfeeding jaundice.

Purpose of the Study:

  • To evaluate current clinical practices regarding neonatal jaundice.
  • To identify breastfeeding as a primary cause of prolonged neonatal jaundice.
  • To provide guidance for community health practitioners to reduce unnecessary referrals and invasive investigations.

Main Methods:

  • Clinical audit of current practices for neonatal jaundice assessment.
  • Analysis of referral patterns and investigation results for jaundiced neonates.
  • Review of diagnostic criteria for breastfeeding jaundice.

Main Results:

  • Breastfeeding was confirmed as the predominant reason for prolonged jaundice in neonates.
  • Most infants diagnosed with breastfeeding jaundice required only reassurance and monitoring.
  • Current practices may lead to over-referral and unnecessary investigations for otherwise healthy jaundiced infants.

Conclusions:

  • Breastfeeding jaundice is a common and benign condition in newborns.
  • Community health practitioners can be guided to reduce referrals for well neonates with jaundice.
  • Minimizing invasive investigations can improve patient outcomes and healthcare efficiency.

More Related Videos

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...